News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) and CXR Biosciences Conclude Collaboration to Develop In Vitro Assays Using hESC-Derived Hepatocytes


4/24/2007 12:57:38 PM

MENLO PARK, Calif. & DUNDEE, Scotland--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) and CXR Biosciences Ltd. today announced the conclusion of a research collaboration that focused on the development of human embryonic stem cell (hESC)-derived hepatocytes for use in in vitro assays of drug metabolism and toxicity.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES